By Dan Primack
September 20, 2012

BASF has agreed to acquire Becker Underwood, an Ames, Iowa-based provider of seed-applied biological products, from Norwest Equity Partners. The deal is valued at $1.02 billion. NEP first iacquired Becker Underwood back in 2004. www.beckerunderwood.com

Colby Pharmaceutical Co. of San Jose, Calif. has acquired Othera Pharmaceuticals Inc., a Conshohocken, Penn.-based developer of drugs for oncology, ophthalmology, and inflammatory diseases. No financial terms were disclosed. Othera had raised over $40 million in VC funding from Ben Franklin Technology Partners, Commerce Health Ventures, Fletcher Spaght, Johnson & Johnson Development Corp., Liberty Venture Partners, NewSpring Capital, NJTC Venture Fund and Wynnefield Capital Advisors. www.colbypharma.com

Boston Scientific Corp. (NYSE: BSX) has agreed to acquire BridgePoint Medical Inc., a Minneapolis-based developer of devices for crossing coronary and peripheral chronic total occlusions. No financial terms were disclosed. BridgePoint had raised over $26 million in VC fuinding from firms like New Enterprise Associates, Covidien PLC, Polaris Venture Partners and Foundation Medical Partners. www.bridgepointmedical.com

Sign up for Dan’s daily email newsletter on deals and deal-makers: GetTermSheet.com

You May Like

EDIT POST